Definition
The two primary interventions used to prevent malaria in pregnancy are defined here:
- 1.
Intermittent preventive treatment of malaria in pregnancy (IPTp) to reduce malaria infection and its consequences was proven efficacious in the 1990s (Schultz et al. 1994; Parise et al. 1998) and was subsequently recommended by the World Health Organization (WHO) for sub-Saharan African countries where malaria is endemic. IPTp is the provision of a curative dose of an antimalarial drug during pregnancy, irrespective of whether or not malaria parasites are present at the time of treatment. IPTp clears malaria parasites that may be present in the peripheral circulation or sequestered in the placenta and provides a period of chemoprophylaxis, thereby preventing new malaria infections.
- 2.
Insecticide-treated bed nets (ITN) provide a physical barrier and an insecticidal...
This is a preview of subscription content, log in via an institution.
References
Aitken EH, Mbewe B, et al. Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use. PLoS One. 2012;7(1):e29874.
Anders K, Marchant T, et al. Timing of intermittent preventive treatment for malaria during pregnancy and the implications of current policy on early uptake in north-east Tanzania. Malar J. 2008;7:79.
Ashwood-Smith. Availability and use of sulfadoxine pyrimethamine in pregancy in Blantyre District. Malawi Med J. 2002;14(1):4.
Briand V, Bottero J, et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis. 2009;200(6):991–1001.
Brooks MI, Singh N, et al. Control measures for malaria in pregnancy in India. Indian J Med Res. 2008;128(3):246–53.
Chico RM, Chandramohan D. Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy. Expert Opin Drug Metab Toxicol. 2011;7(9):1153–67.
D’Alessandro U, ter Kuile FO. Amodiaquine, malaria, pregnancy: the old new drug. Lancet. 2006;368(9544):1306–7.
Desai M, ter Kuile FO, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7(2):93–104.
Diakite OS, Kayentao K, et al. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. Clin Infect Dis. 2011;53(3):215–23.
Eisele TP, Larsen DA, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12(12):942–9.
Filler SJ, Kazembe P, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis. 2006;194(3):286–93.
Gamble C, Ekwaru PJ, et al. Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials. PLoS Med. 2007;4(3), e107.
Garner P, Gulmezoglu AM. Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev. 2006;4, CD000169.
Gies S, Coulibaly SO, et al. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso. Am J Trop Med Hyg. 2009;80(3):460–9.
Gimnig JE, MacArthur JR, et al. Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi. Am J Trop Med Hyg. 2006;74(5):738–43.
Greenwood B, Alonso P, et al. Malaria in pregnancy: priorities for research. Lancet Infect Dis. 2007;7(2):169–74.
Gross K, Alba S, et al. The combined effect of determinants on coverage of intermittent preventive treatment of malaria during pregnancy in the Kilombero Valley, Tanzania. Malar J. 2011;10:140.
Hamel MJ, Greene C, et al. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg. 2008;79(3):320–30.
Harrington WE, Morrison R, et al. Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring. PLoS One. 2013;8(2), e56183.
Hawley WA, Phillips-Howard PA, et al. Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya. Am J Trop Med Hyg. 2003;68(4 Suppl):121–7.
Hill J, Hoyt J, et al. Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013;10(7), e1001488.
Kayentao K, Garner P, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309(6):594–604.
Kyabayinze DJ, Tibenderana JK, et al. Placental Plasmodium falciparum malaria infection: operational accuracy of HRP2 rapid diagnostic tests in a malaria endemic setting. Malar J. 2011;10:306.
Mbonye AK, Bygbjerg I, et al. Intermittent preventive treatment of malaria in pregnancy: evaluation of a new delivery approach and the policy implications for malaria control in Uganda. Health Policy. 2007;81(2–3):228–41.
McGready R, Boel M, et al. Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986–2010. PLoS One. 2012;7(7), e40244.
Menendez C, D’Alessandro U, et al. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis. 2007;7(2):126–35.
Menendez C, Bardaji A, et al. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS One. 2010;5(2), e9438.
Mermin J, Ekwaru JP, et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet. 2006;367(9518):1256–61.
Msyamboza KP, Savage EJ, et al. Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Trop Med Int Health. 2009;14(2):183–9.
Ndyomugyenyi R, Tukesiga E, et al. Intermittent preventive treatment of malaria in pregnancy (IPTp): participation of community-directed distributors of ivermectin for onchocerciasis improves IPTp access in Ugandan rural communities. Trans R Soc Trop Med Hyg. 2009;103(12):1221–8.
Okeibunor JC, Orji BC, et al. Preventing malaria in pregnancy through community-directed interventions: evidence from Akwa Ibom State, Nigeria. Malar J. 2011;10:227.
Parise ME, Ayisi JG, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg. 1998;59(5):813–22.
Partnership RBM. The global Malaria action plan – for a malaria-free world. Geneva: WHO; 2008. p. 274.
Picot S, Olliaro P, et al. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009;8:89.
Sangare LR, Stergachis A, et al. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda. PLoS One. 2010;5(11), e15066.
Schultz LJ, Steketee RW, et al. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg. 1994;51(5):515–22.
Tagbor H, Bruce J, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One. 2010;5(12), e14425.
Takem EN, D’Alessandro U. Malaria in pregnancy. Mediterr J Hematol Infect Dis. 2013;5(1), e2013010.
ter Kuile FO, van Eijk AM, et al. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297(23):2603–16.
USAID C. The president’s malaria initiative, fifth annual report to congress. Washington, DC: U.S. Agency for International Development, 2011. p. 90.
van Eijk AM, Hill J, et al. Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data. Lancet Infect Dis. 2011;11(3):190–207.
Venkatesan M, Alifrangis M, et al. Monitoring antifolate resistance in intermittent preventive therapy for malaria. Trends Parasitol. 2013;29(10):497–504.
WHO. Lives at risk: malaria in pregnancy. WHO; 2003.
WHO. Updated WHO policy recommendation (2012a), intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). WHO; 2012a/2013.
WHO. World malaria report, 2012. WHO; 2012b. p. 124.
WHO. Core vector control methods. WHO; 2013.
Acknowledgements
The conclusions, findings, and opinions expressed by the authors do not necessarily reflect the official position of the Centers for Disease Control and Prevention.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science Business Media New York (outside the USA)
About this entry
Cite this entry
Hamel, M.J., D’Alessandro, U. (2015). Control of Malaria During Pregnancy: Preventive Strategies. Intermittent Preventive Treatment and Insecticide-Treated Nets. In: Hommel, M., Kremsner, P. (eds) Encyclopedia of Malaria. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8757-9_71-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8757-9_71-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-8757-9
eBook Packages: Springer Reference MedicineReference Module Medicine